The Occurrence of Metabolic Syndrome In Patients With Psoriasis

Musarrat Hussain Raza; Nadia Iftikhar; Asher Ahmed Mashhood; Muhammad Ammar Bin Hamid; Shahan Tariq; Farhat Rehman

doi:10.51253/pafmj.v74iSUPPL-2.6399

Authors

Musarrat Hussain Raza Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan
Nadia Iftikhar Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan
Asher Ahmed Mashhood Department of Dermatology, Combined Military Hospital Rawalpindi / National University of Medical Sciences (NUMS) Pakistan
Muhammad Ammar Bin Hamid Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan
Shahan Tariq Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan
Farhat Rehman Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74iSUPPL-2.6399

Keywords:

Body mass Index, Metabolic Syndrome, Psoriasis

Abstract

Objective: To determine occurrence of metabolic syndrome in patients of Psoriasis and to highlight any gender-based differences.

Study Design: Cross-sectional study design.

Place and Duration of Study: Pak-Emirates Military Hospital, Rawalpindi. Our research was conducted from July to December 2020 (6 months).

Patients and Methods: A total of 80 patients diagnosed with psoriasis were selected using non-probability consecutive sampling. Informed written consent was obtained from each patient and a questionnaire was filled. Variables such as blood pressure, waist circumference, body surface area covered by psoriasis, and Psoriasis Area Severity Index were recorded on initial visit. Fasting blood sugar, serum triglyceride and HDL cholesterol levels were advised. Patients were diagnosed to have metabolic syndrome if 3 or more of the 5 criteria for the modified version of the National Cholesterol Education Program Adult Panel III were met.

Results: There were 62 male & 18 female patients. A total of 39 patients (48.8%) met the criteria for metabolic syndrome. Amongst these, 26/62(41.9%) males & 13/18(72.2%) females fulfilled the criteria. The mean BMI of males was 26.0 and those of females was 28.3 & their comparison demonstrated a noteworthy difference (p=0.04). A statistically significant (p=0.038) positive correlation (r) of 0.233 was observed between body surface area and BMI.

Conclusion: Metabolic syndrome is seen frequently in patients of Psoriasis. Female patients have a significant frequency of metabolic syndrome and tend to have a higher BMI than males.

Downloads

Download data is not yet available.

Author Biography

Shahan Tariq, Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi / National University of Medical Sciences (NUMS) Pakistan

House Officer

References

Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg. 2016 Jul 1; 33(3): 355-66.

Griffiths CE, van der Walt JM, Ashcroft DM, Flohr C, Naldi L, Nijsten T et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol Title. 2017 Jul; 177(1): e4-7.

Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017 Feb; 31(2): 205-12.

Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017 Sep 1; 140(3): 645-53.

Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018 Mar; 45(3): 264-72.

McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018 Jan 1; 36(1): 14-20.

Singh S, Young P, Armstrong AW. An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies. PLoS One. 2017 Jul 18; 12(7): e0181039.

Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018 Jan 1; 36(1): 21-8.

Manolis AA, Manolis TA, Melita H, Manolis AS. Psoriasis and cardiovascular disease: the elusive link. Int Rev Immunol. 2019 Jan 2; 38(1): 33-54.

Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med. 2007 Aug 13; 167(15): 1670-5.

Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol. 2012 Mar; 39(3): 212-8.

Birarra MK, Gelayee DA. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study. BMC Cardiovasc Disord. 2018 Dec; 18(1): 1-2.

Lan Y, Mai Z, Zhou S, Liu Y, Li S, Zhao Z et al. Prevalence of metabolic syndrome in China: An up-dated cross-sectional study. PloS one. 2018 Apr 18; 13(4): e0196012.

Jensen P, Skov L. Psoriasis and obesity. Dermatology. 2016; 232(6): 633-9.

Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study. Br J Dermatol. 2007 Jul; 157(1): 68-73.

Ghias A, Khan MS, Shaheen E. Frequency of metabolic syndrome in patients of psoriasis. J. Pakistan Assoc. Dermatologists. 2018 Jul 23; 28(1): 73-8.

Hassan BS, Akhtar N, kumar Paul H, Biswas C, Hossain MA, Wahab MA, Zakaria AS. Rate of metabolic syndrome in psoriasis. J.Pakistan Assoc.Dermatologists. 2017 Jun 13; 27(1): 48-53.

Azfar NA, Malik LM, Khan IU, Ahsan U, Rashid T, Jahangir M. Frequency of Metabolic Syndrome in patients of Psoriasis. J Allama Iqbal Med Coll.2019,17(01) 145-7.